European American cases studied
Group . | *IgH FISH *14q32 break apart . | *4;14 . | *11;14 . | *14;16 . | *14q32 NOS . | aCGH . | GEP . |
---|---|---|---|---|---|---|---|
Mayo Clinic | — | — | — | — | — | — | — |
E4A03 | 239 | 278 | 279 | 271 | 147 | — | — |
E9487 | 114 | 114 | — | 114 | — | — | — |
MMRC | — | — | — | — | — | 196 | 178 |
*Totals | 353 | 392 | 279 | 385 | 147 | 196 | 178 |
Group . | *IgH FISH *14q32 break apart . | *4;14 . | *11;14 . | *14;16 . | *14q32 NOS . | aCGH . | GEP . |
---|---|---|---|---|---|---|---|
Mayo Clinic | — | — | — | — | — | — | — |
E4A03 | 239 | 278 | 279 | 271 | 147 | — | — |
E9487 | 114 | 114 | — | 114 | — | — | — |
MMRC | — | — | — | — | — | 196 | 178 |
*Totals | 353 | 392 | 279 | 385 | 147 | 196 | 178 |
Dashes (−) indicate no samples from the specified group were used for the analysis.
Patients were selected for study of IgH translocations on the basis of the availability of samples for FISH investigation. Numbers for FISH analysis of 14q32 break-apart and translocation partners (4;14, 11;14, 14;16, and 14q32NOS) reflect the amount of samples analyzed, excluding those that were missing or not available.